by Team Small News | Jun 13, 2025 | Aurobindo Pharma, Pharma
On Thursday, a ceremony was held in Pydibhimavaram, Srikakulam district, to award certificates to 28 students who successfully completed a course on “Pharmaceutical Quality Control Analytical Techniques”. The certificates were handed over by K. Kamalakar... by Team Small News | Jun 6, 2025 | Aurobindo Pharma, Pfizer, Pharma
The US Food and Drug Administration (FDA) has granted approval to Aurobindo Pharma for its varenicline tablets, available in 0.5 mg and 1 mg strengths. This approval marks a significant milestone for Aurobindo, as its varenicline tablets are the generic equivalent of...
by Team Small News | May 22, 2025 | Aurobindo Pharma, Natco, Pharma, Piramal Pharma, Zydus
The Indian pharmaceutical sector has demonstrated robust growth over the past year, driven by a new trade agreement with the European Union that reduces tariffs on key drug exports. This agreement is expected to enhance India’s position as a global supplier of... by Team Small News | May 22, 2025 | Aurobindo Pharma, Pharma
A recent US district court ruling has brought relief to Acadia Pharmaceuticals, the manufacturer of Nuplazid, a medication used to treat hallucinations and delusions associated with Parkinson’s disease psychosis. The court’s decision has upheld the... by Team Small News | May 17, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma, a leading generic drug manufacturer, has launched a six-month post-graduation certification in leadership (CLP) program at the Institute of Management Technology, Hyderabad (IMT Hyderabad). The program, introduced through Aurobindo’s... by Team Small News | May 9, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma
The India Active Pharmaceutical Ingredients (API) market is expected to experience significant growth, with an estimated value of USD 14.81 billion in 2025 and a projected value of USD 25.23 billion by 2032, at a compound annual growth rate (CAGR) of 7.9%. This growth...